Dasabuvir (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dasabuvir" in English language version.

refsWebsite

Global rank English rank

6web.archive.org

1^st place

1^st place

68^th place

117^th place

102^nd place

76^th place

447^th place

338^th place

4^th place

4^th place

399^th place

333^rd place

1books.google.com

3^rd place

3^rd place

5^th place

5^th place

4,294^th place

6,357^th place

low place

9,301^st place

books.google.com

Časar, Zdenko (2016). Synthesis of Heterocycles in Contemporary Medicinal Chemistry. Springer. p. 92. ISBN 9783319399171. Archived from the original on 2016-12-20.

drugbank.ca

"The DrugBank database". www.drugbank.ca/drugs/DB09183. Archived from the original on 2016-11-11. Retrieved 2016-10-28.

drugs.com

"Viekira Pak". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.

europa.eu

ema.europa.eu

"Exviera EPAR". European Medicines Agency (EMA). Retrieved 13 October 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"European Medicines Agency - Find medicine - Exviera". www.ema.europa.eu. 24 May 2016. Archived from the original on 10 November 2016. Retrieved 2016-11-09.
"Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)". European Medicines Agency (EMA). 17 September 2018. Retrieved 4 February 2020.

fda.gov

Commissioner, Office of the. "Safety Information - Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), Copackaged for Oral Use". www.fda.gov. Archived from the original on 2016-11-17. Retrieved 2016-11-17.
"FDA Drug Safety Communication: FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie". U.S. Food and Drug Administration (FDA). 24 August 2016. Retrieved 13 October 2020. This article incorporates text from this source, which is in the public domain.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2015). The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children). World Health Organization. p. 73. hdl:10665/189763. ISBN 9789241209946. ISSN 0512-3054. WHO technical report series;994.

nih.gov

dailymed.nlm.nih.gov

"Viekira Pak- dasabuvir and ombitasvir and paritaprevir and ritonavir kit". DailyMed. 12 December 2019. Retrieved 13 October 2020.

uw.edu

hepatitisc.uw.edu

"Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir (Viekira Pak) - Treatment - Hepatitis C Online". www.hepatitisc.uw.edu. Archived from the original on 2016-11-01. Retrieved 2016-11-09.

web.archive.org

"Viekira Pak". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
"European Medicines Agency - Find medicine - Exviera". www.ema.europa.eu. 24 May 2016. Archived from the original on 10 November 2016. Retrieved 2016-11-09.
Časar, Zdenko (2016). Synthesis of Heterocycles in Contemporary Medicinal Chemistry. Springer. p. 92. ISBN 9783319399171. Archived from the original on 2016-12-20.
Commissioner, Office of the. "Safety Information - Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), Copackaged for Oral Use". www.fda.gov. Archived from the original on 2016-11-17. Retrieved 2016-11-17.
"The DrugBank database". www.drugbank.ca/drugs/DB09183. Archived from the original on 2016-11-11. Retrieved 2016-10-28.
"Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir (Viekira Pak) - Treatment - Hepatitis C Online". www.hepatitisc.uw.edu. Archived from the original on 2016-11-01. Retrieved 2016-11-09.

worldcat.org

search.worldcat.org

World Health Organization (2015). The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children). World Health Organization. p. 73. hdl:10665/189763. ISBN 9789241209946. ISSN 0512-3054. WHO technical report series;994.